174 related articles for article (PubMed ID: 7416907)
1. Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies.
Ravaris CL; Robinson DS; Ives JO; Nies A; Bartlett D
Arch Gen Psychiatry; 1980 Sep; 37(9):1075-80. PubMed ID: 7416907
[TBL] [Abstract][Full Text] [Related]
2. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
Paykel ES; Rowan PR; Parker RR; Bhat AV
Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
[TBL] [Abstract][Full Text] [Related]
3. Phenelzine and amitriptyline: effects on symptoms of neurotic depression.
Rowan PR; Paykel ES; Parker RR
Br J Psychiatry; 1982 May; 140():475-83. PubMed ID: 7049292
[TBL] [Abstract][Full Text] [Related]
4. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
Raft D; Davidson J; Wasik J; Mattox A
Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
[TBL] [Abstract][Full Text] [Related]
5. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
[TBL] [Abstract][Full Text] [Related]
7. Forms of atypical depression and their response to antidepressant drugs.
Davidson J; Pelton S
Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445
[TBL] [Abstract][Full Text] [Related]
8. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
[TBL] [Abstract][Full Text] [Related]
9. Response to phenelzine among depressed patients with features of hysteroid dysphoria.
Kayser A; Robinson DS; Nies A; Howard D
Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
Georgotas A; McCue RE; Friedman E; Cooper TB
J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
[TBL] [Abstract][Full Text] [Related]
12. A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.
Kay DW; Garside RF; Fahy TJ
Br J Psychiatry; 1973 Jul; 123(572):63-7. PubMed ID: 4580991
[No Abstract] [Full Text] [Related]
13. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression.
Davidson J; McLeod M; Law-Yone B; Linnoila M
Arch Gen Psychiatry; 1978 May; 35(5):639-42. PubMed ID: 727903
[TBL] [Abstract][Full Text] [Related]
14. Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo.
Gelenberg AJ; Wojcik JD; Falk WE; Spring B; Brotman AW; Galvin-Nadeau M
Compr Psychiatry; 1990; 31(4):307-14. PubMed ID: 2201481
[TBL] [Abstract][Full Text] [Related]
15. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
[TBL] [Abstract][Full Text] [Related]
16. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
[TBL] [Abstract][Full Text] [Related]
17. A double-blind study of the efficacy and safety of dothiepin hydrochloride in the treatment of major depressive disorder.
Stratas NE
J Clin Psychiatry; 1984 Nov; 45(11):466-9. PubMed ID: 6386793
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
Tyrer P
J Affect Disord; 1984 Feb; 6(1):1-7. PubMed ID: 6231324
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
Georgotas A; McCue RE; Hapworth W; Friedman E; Kim OM; Welkowitz J; Chang I; Cooper TB
Biol Psychiatry; 1986 Oct; 21(12):1155-66. PubMed ID: 3756264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
